Travis C Mickle - Net Worth and Insider Trading
Travis C Mickle Net Worth
The estimated net worth of Travis C Mickle is at least $1 Million dollars as of 2024-11-13. Travis C Mickle is the President & CEO of Zevra Therapeutics Inc and owns about 171,774 shares of Zevra Therapeutics Inc (ZVRA) stock worth over $1 Million. Details can be seen in Travis C Mickle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Travis C Mickle has not made any transactions after 2022-05-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Travis C Mickle
Travis C Mickle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Travis C Mickle owns 1 companies in total, including Zevra Therapeutics Inc (ZVRA) .
Click here to see the complete history of Travis C Mickle’s form 4 insider trades.
Insider Ownership Summary of Travis C Mickle
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2022-05-25 | director & 10 percent owner & President & CEO |
Travis C Mickle Latest Holdings Summary
Travis C Mickle currently owns a total of 1 stock. Travis C Mickle owns 171,774 shares of Zevra Therapeutics Inc (ZVRA) as of May 25, 2022, with a value of $1 Million.
Latest Holdings of Travis C Mickle
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2022-05-25 | 171,774 | 8.57 | 1,472,103 |
Holding Weightings of Travis C Mickle
Travis C Mickle Form 4 Trading Tracker
According to the SEC Form 4 filings, Travis C Mickle has made a total of 6 transactions in Zevra Therapeutics Inc (ZVRA) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Zevra Therapeutics Inc is the acquisition of 13,000 shares on May 25, 2022, which cost Travis C Mickle around $56,940.
Insider Trading History of Travis C Mickle
- 1
Travis C Mickle Trading Performance
GuruFocus tracks the stock performance after each of Travis C Mickle's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Travis C Mickle is -1.42%. GuruFocus also compares Travis C Mickle's trading performance to market benchmark return within the same time period. The performance of stocks bought by Travis C Mickle within 3 months outperforms 4 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Travis C Mickle's insider trading performs compared to the benchmark.
Performance of Travis C Mickle
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.41 | | | | | |
| Relative Return to S&P 500(%) | -0.61 | | | | | |
Travis C Mickle Ownership Network
Ownership Network List of Travis C Mickle
Ownership Network Relation of Travis C Mickle
Travis C Mickle Owned Company Details
What does Zevra Therapeutics Inc do?
Who are the key executives at Zevra Therapeutics Inc?
Travis C Mickle is the director & 10 percent owner & President & CEO of Zevra Therapeutics Inc. Other key executives at Zevra Therapeutics Inc include VP Fin & Corp Controller R. Laduane Clifton , director & President and CEO Neil F. Mcfarlane , and CCO & EVP & Bus. Development Joshua Schafer .
Zevra Therapeutics Inc (ZVRA) Insider Trades Summary
Over the past 18 months, Travis C Mickle made no insider transaction in Zevra Therapeutics Inc (ZVRA). Other recent insider transactions involving Zevra Therapeutics Inc (ZVRA) include a net purchase of 1,500 shares made by Watton Corey Michael , a net purchase of 30,000 shares made by John B Bode , and a net purchase of 5,740 shares made by R. Laduane Clifton .
In summary, during the past 3 months, insiders sold 0 shares of Zevra Therapeutics Inc (ZVRA) in total and bought 500 shares, with a net purchase of 500 shares. During the past 18 months, 0 shares of Zevra Therapeutics Inc (ZVRA) were sold and 58,740 shares were bought by its insiders, resulting in a net purchase of 58,740 shares.
Zevra Therapeutics Inc (ZVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zevra Therapeutics Inc Insider Transactions
Travis C Mickle Mailing Address
Above is the net worth, insider trading, and ownership report for Travis C Mickle. You might contact Travis C Mickle via mailing address: 2656 Crosspark Road, Suite 100, Coralville Ia 52241.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
